ZAI LAB LIMITED
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $460.2M | $399.0M | $266.7M | $215.0M | $144.3M | $49.0M | $13.0M | $129.0K |
| Cost of Revenue | $190.5M | $147.1M | $95.8M | $74.0M | $52.2M | $16.7M | $3.7M | $43.0K |
| Gross Profit | $269.6M | $251.9M | $170.9M | $141.0M | $92.1M | $32.2M | $9.2M | $86.0K |
| Gross Margin | 58.6% | 63.1% | 64.1% | 65.6% | 63.8% | 65.8% | 71.1% | 66.7% |
| Operating Expenses | ||||||||
| Research & Development | $220.9M | $234.5M | $265.9M | $286.4M | $573.3M | $222.7M | $142.2M | $120.3M |
| SG&A Expense | $277.6M | $298.7M | $281.6M | $259.0M | $218.8M | $111.3M | $70.2M | $21.6M |
| Operating Income | $-229.4M | $-282.1M | $-366.6M | $-404.4M | $-700.1M | $-301.8M | $-203.2M | $-141.8M |
| Operating Margin | -49.9% | -70.7% | -137.4% | -188.0% | -485.1% | -616.4% | -1,564.9% | -109,897.7% |
| Interest Expense | — | $2.3M | $0 | $0 | $0 | $181.0K | $293.0K | $40.0K |
| Pretax Income | $-178.5M | $-257.1M | $-334.6M | $-443.3M | $-704.5M | $-268.9M | $-195.1M | $-139.1M |
| Income Tax Expense | $-2.9M | $0 | $0 | $0 | $0 | $0 | — | — |
| Net Income | $-175.5M | $-257.1M | $-334.6M | $-443.3M | $-704.5M | $-268.9M | $-195.1M | $-139.1M |
| Net Margin | -38.1% | -64.4% | -125.5% | -206.1% | -488.2% | -549.3% | -1,502.3% | -107,810.1% |
| EPS (Basic) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 | $-0.35 | $-3.03 | $-2.64 |
| EPS (Diluted) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 | $-0.35 | $-3.03 | $-2.64 |
| Shares Outstanding (Basic) | 1.10B | 989.5M | 966.4M | 958.1M | 929.9M | 776.7M | 68.2M | — |
| Shares Outstanding (Diluted) | 1.10B | 989.5M | 966.4M | 958.1M | 929.9M | 776.7M | 68.2M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |